Nuveen Asset Management’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-107,352
| Closed | -$1.25M | – | 3499 |
|
|
2022
Q1 | $1.25M | Buy |
107,352
+54,447
| +103% | +$631K | ﹤0.01% | 2721 |
|
|
2021
Q4 | $672K | Sell |
52,905
-6,079
| -10% | -$77.2K | ﹤0.01% | 2986 |
|
|
2021
Q3 | $773K | Sell |
58,984
-1,867
| -3% | -$24.5K | ﹤0.01% | 3074 |
|
|
2021
Q2 | $1.05M | Buy |
60,851
+11,247
| +23% | +$193K | ﹤0.01% | 2989 |
|
|
2021
Q1 | $907K | Buy |
49,604
+5,528
| +13% | +$101K | ﹤0.01% | 2916 |
|
|
2020
Q4 | $829K | Buy |
44,076
+8,864
| +25% | +$167K | ﹤0.01% | 2874 |
|
|
2020
Q3 | $743K | Buy |
35,212
+10,640
| +43% | +$225K | ﹤0.01% | 2808 |
|
|
2020
Q2 | $709K | Buy |
24,572
+11,332
| +86% | +$327K | ﹤0.01% | 2765 |
|
|
2020
Q1 | $463K | Buy |
+13,240
| New | +$463K | ﹤0.01% | 2799 |
|